A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD8154 Following Single Ascending Dose Administration in Healthy Subjects

Trial Profile

A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD8154 Following Single Ascending Dose Administration in Healthy Subjects

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2018

At a glance

  • Drugs AZD-8154 (Primary) ; AZD-8154 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; First in man
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top